A 2-Year Retrospective Case Series on Isolates of the Emerging Pathogen from a Canadian Tertiary Care Hospital.

(1) Background: is an emerging, opportunistic pathogen often linked with UTIs but can extend beyond the urogenital system. Data on the clinical significance of are still emerging. (2) Methods: A retrospective review of isolates in a Canadian tertiary care hospital was conducted. The clinical data of patients that grew from January 2020 to 2022 were documented. Demographics, site, management, and microbiological parameters surrounding culture and sensitivities were recorded. (3) Results: A total of 43 cases of were identified. was primarily involved in UTIs ( = 17), abscesses ( = 9), bacteremia ( = 6), septic arthritis ( = 5), and ulcers ( = 5). had a slight predilection for polymicrobial infections (51.1%, = 22 out of 43), with ( = 5) being the most common coisolate. Susceptibility testing was only performed in two cases that showed sensitivity to beta-lactam antibiotics and resistance to metronidazole and ciprofloxacin. Amoxicillin-clavulanate ( = 5) is the most frequently prescribed antibiotic. (4) Conclusions: The non-urogenic clinical significance of remains undervalued. The management of infection is multimodal, consisting predominantly of antimicrobials and surgical procedures specific to the etiology. Clinicians should request sensitivities for so that appropriate antimicrobial coverage can be provided.